Poorly differentiated colorectal cancers: Correlation of microsatellite instability with clinicopathologic features and survival

American Journal of Clinical Pathology

Volumn 140, Issue 3, 2013, Pages 341-347

  Xiao, Haitao ^a,b   Yoon, Yong Sik ^a,b   Hong, Seung Mo ^a   Roh, Seon Ae ^a,c   Cho, Dong Hyung ^c,d   Yu, Chang Sik ^a   Kim, Jin Cheon ^a,c  

^a University of Ulsan College of Medicine   (South Korea)

^b Beijing United Family Hospital   (China)

^c Asan Medical Center   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

Colorectal adenocarcinoma; Microsatellite instability; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; OVERALL SURVIVAL; PRIORITY JOURNAL;

COLORECTAL ADENOCARCINOMA; MICROSATELLITE INSTABILITY; PROGNOSIS;

ADULT; AGED; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84882763936     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP8P2DYNKGRBVI     Document Type: Article

References (27)

1. Haydon AM, Jass JR. Emerging pathways in colorectalcancer development. Lancet Oncol. 2002;3:83-88.
2. Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342:69-77.
3. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23:609-618.
4. Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. In: World Health Organization Classification of Tumours. Lyons, France: IARC Press; 2000:110-111.
5. Benedix F, Kube R, Meyer F, et al. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum. 2010;53:57-64.
6. Ishihara S, Watanabe T, Akahane T, et al. Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon. Int J Colorectal Dis. 2012;27:371-379.
7. Yoshida T, Akagi Y, Kinugasa T, et al. Clinicopathological study on poorly differentiated adenocarcinoma of the colon. Kurume Med J. 2011;58:41-46.
8. Bjerkeset T, Morild I, Mørk S, et al. Tumor characteristics in colorectal cancer and their relationship to treatment and prognosis. Dis Colon Rectum. 1987;30:934-938.
9. Kazama Y, Watanabe T, Kanazawa T, et al. Poorly differentiated colorectal adenocarcinomas show higher rates of microsatellite instability and promoter methylation of p16 and hMLH1: a study matched for T classification and tumor location. J Surg Oncol. 2008;97:278-283.
10. Kazama Y, Watanabe T, Kanazawa T, et al. Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: relationship to clinicopathological features. J Clin Pathol. 2007;60:701-704.
11. Yoon YS, Yu CS, Kim TW, et al. Mismatch repair status in sporadic colorectal cancer: immunohistochemistry and microsatellite instability analyses. J Gastroenterol Hepatol. 2011;26:1733-1739.
12. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
13. Lanza G, Gafa R, Santini A, et al. Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J Clin Oncol. 2006;24:2359-2367.
14. Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349:247-257.
15. Ward R, Meagher A, Tomlinson I, et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut. 2001;48:821-829.
16. Greenson JK, Huang SC, Herron C, et al. Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol. 2009;33:126-133.
17. Zhang H, Richards B, Wilson T, et al. Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res. 1999;59:3021-3027.
18. Deng G, Bell I, Crawley S, et al. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004;10:191-195.
19. Kim JC, Roh SA, Cho DH, et al. Chemoresponsiveness associated with canonical molecular changes in colorectal adenocarcinomas. Anticancer Res. 2009;29:3115-3123.
20. Lim SB, Yu CS, Jang SJ, et al. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum. 2010;53:377-384.
21. Stacker SA, Achen MG, Jussila L, et al. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002;2:573-583.
22. Karpanen T, Alitalo K. Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol. 2008;3:367-397.
23. Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 2005;6:322-327.
24. Kim JC, Roh SA, Lee KH, et al. Genetic and pathologic changes associated with lymphovascular invasion of colorectal adenocarcinoma. Clin Exp Metastasis. 2005;22:421-428.
25. Alexander J, Watanabe T, Wu TT, et al. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol. 2001;158:527-535.
26. Carethers JM, Smith EJ, Behling CA, et al. Use of 5-fluorouracil and survival in patients with microsatelliteunstable colorectal cancer. Gastroenterology. 2004;126:394-401.
27. Jover R, Zapater P, Castells A, et al. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer. 2009;45:365-373.